Nancy Miller-Rich
Directorat4D Molecular Therapeutics· In proxies 2023–2025
Nancy Miller-Rich sits on 4 public boards.
Experience
- 4D Molecular TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -36%
- Aldeyra Therapeutics, Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- Attralus, Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- Intercept Pharmaceuticals, Inc.Public company · 5 yr
- Director2018 – 2023 · 5 yrNo stock prices for these years
- Kadmon Holdings, Inc.Public company · 1 yr
- Director2020 – 2021 · 1 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?